Abrezekimab (Synonyms: UCB4144; VR 942) |
| Catalog No.GC68595 |
Abrezekimab (VR 942) contains CDP7766, which is a humanized, high-affinity, neutralizing anti-human IL-13 antibody fragment that can bind to IL-13. Abrezekimab blocks the binding of IL-13 to the IL-13Rα1 subunit. Abrezekimab can be used for research on asthma.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2043952-59-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Abrezekimab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Abrezekimab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *